Lupin Limited (NSE:LUPIN) (BSE:500257)
Lupin limited is an India-based transnational pharmaceutical Company, producing a wide range of generic and branded formulations. The Company has market share in key markets in the cardiovascular (prils and statins), diabetology, asthma, pediatrics, CNS, GI, anti-infective and NSAIDs therapy segments, Anti-TB and, cephalosporins segments. The Company’s key divisions in India are Pinnacle Cardiology, Lupin metabolics, Lupin blue eyes, Lupin CVN, Lupin diabetes care, respira, endeavour, Lupin Mindvision, Lupin Ikonic, Lupin Maxter, anti-tuberculosis, anti-biotics, gynaecology, orthopaedic and dermatology division. The Company is a key player in India’s respiratory (anti-asthma) segment, cardiovascular segment and the diabetes segment.
Official website: www.lupinworld.com